Triple-negative breast cancer (TNBC) is among the most aggressive breast cancer subtypes, with high metastasis and recurrence rates, as well as poor survival. While various molecular targets for TNBC ...

Barclays analyst Emily Field maintained a Buy rating on Genmab A/S (0MGB – Research Report) today and set a price target of DKK2,100.00. The ...

Amidst a backdrop of uncertainty in the European markets, with the pan-European STOXX Europe 600 Index recently declining by 1.23% due to concerns over U.S. trade tariffs and monetary policy, ...

In a report released today, Jo Walton from UBS maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of ...

Revenue: DKK5.7 billion for 2024. EBITDA Margin: 28%, equating to DKK1.6 billion. Travel Health Vaccine Growth: 22% increase compared to the previous year. Public Preparedness Revenue: DKK3.2 ...

So you can all see the figures on this slide. Just over DKK5.7 billion in revenue, 28% EBITDA margin, which equates to DKK1.6 billion. So very strong year based on strong growth of our Travel ...

BNP Paribas (OTC:BNPQY) Exane also upgraded Genmab's shares from Underperform to Neutral, adjusting the price target to DKK1,500, while noting cautious optimism surrounding the anticipated ...

Activation of Wnt signalling was assessed by analysing Axin2 mRNA levels and by staining for β-catenin. Results The promoters of DKK1 and SFRP1 were hypermethylated in fibroblasts and peripheral blood ...

Improved lottery performance and the increased gross gaming revenue also led to Danske Spil’s net profit after tax rising by DKK124m (£13.98m), or 6.8 per cent, to DKK1.95bn (£219.6m). The operator ...

Want More News Like This? CAPA Membership provides access to all news and analysis on the site, along with access to many areas of our comprehensive databases and toolsets.